SUBSCRIBE

Breaking News on Supplements, Health & Nutrition - Europe US edition | APAC edition

Read more breaking news

 

 

FrieslandCampina lactoferrin ingredient granted EC novel foods approval

By Mark Astley , 05-Dec-2012
Last updated on 11-Dec-2012 at 09:13 GMT2012-12-11T09:13:00Z

FrieslandCampina lactoferrin ingredient granted novel foods approval

The European Commission (EC) has given Dutch dairy giant FrieslandCampina the go-ahead to market bovine lactoferrin as a novel food ingredient.

Last week, the EC published its decision to approve lactoferrin produced by FrieslandCampina as a novel food - meaning it can now be used across the European Union (EU) in a variety of foods, including infant, medical and sports nutrition products.

Bovine lactoferrin (bLF) is a protein that occurs naturally in cow’s milk. It is also found naturally in human breast milk, but at much higher levels.

FrieslandCampina’s bovine lactoferrin product, which is marketed as Vivinal LF, is concentrated from cow's milk to mimic the lactoferrin present in breast milk.

It is already available as an ingredient and in FrieslandCampina infant formula products in parts of Asia and the US – where it has regulatory approval.

Speaking with DairyReporter.com, FrieslandCampina spokesperson Jan Willem ter Avest revealed that the ingredient will be available immediately. It may also be added to its European infant formula range in future.

No health risks

The EC announcement represents the end of a long, scientific process, said ter Avest.

“We started the process in 2009. It has taken three years. First it was assessed by the Dutch government, then by each of the European Union Member States, then finally by EFSA. None of them discovered any health risks.”

“The European Commission publication was the final step in this procedure.”

“We have been given this novel food approval, but it is important to reiterate that this is not the same as a health claim,” ter Avest added.

FrieslandCampina Ingredients chief operating officer (COO) Roelof Joosten welcomed the EC decision.

“Lactoferrin is directly derived from cow’s milk, one of the most nutritious foods there is. New ingredients do not often get approval from the European Commission, and particularly not for infant nutrition. This new authorisation will enable us and our customers to use our lactoferrin in various foods throughout Europe,” said Joosten.

EFSA approval

The EC based its decision on an assessment by the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). The assessment, which was carried out following a request from the EC, concluded that bovine lactoferrin was safe for human consumption.

The Panel noted that lactoferrin is a normal constituent of human milk, and that the intended consumption of bovine lactoferrin – as specified by FrieslandCampina – was well within the levels of breast milk.

“The Panel considers that bLF up to the highest dose (2,000mg/kg bw per day) tested in this subchronic rat study did not show adverse effects which could be attributed to the test substance,” said the EFSA opinion.

“The Panel concludes that the novel food ingredient bLF is safe under the proposed uses and use levels.”

Related products

Live Supplier Webinars

Polyphenols tipped to become the way to innovate in Sports Nutrition
Fytexia
Orally bioavailable standardized botanical derivatives in sport nutrition: special focus on recovery in post-intense physical activities
Indena
Collagen in motion: move freely and keep your injuries in check
Leading manufacturer of gelatine and collagen peptides
Life’s too short for slow proteins. Whey proteins hydrolysates: Fast delivery for enhanced performance
Arla Foods Ingredients
What it Takes to Compete and Win in Today’s Sports Nutrition Market
Capsugel
Sports Nutrition Snapshot: Key regional drivers and delivery format innovations
William Reed Business Media
Gutsy performance: How can microbiome modulation help athletes and weekend warriors
William Reed Business Media
Pushing the boundaries: Where’s the line between ‘cutting edge nutrition’ and doping
William Reed Business Media
Alpha & Omega in Sports Nutrition – Using Omega 3’s and A-GPC to improve performance and recovery.
KD Pharma

On demand Supplier Webinars

High-amylose maize starch may reduce the risk of type 2 diabetes: what does this qualified health claim mean?
Ingredion
Balancing Innovation and Risk in Sports Nutrition Ingredients
NSF-International
Explaining bio-hacking: is there a marketing opportunity for food companies?
William Reed Business Media
Personalized Nutrition – how an industry can take part in shaping the future of Nutrition
BASF Nutrition & Health
Find out Nutritional and ingredient lifecycle solutions and strategies!
Roquette
Is the time rIpe for I-nutrition?
William Reed Business Media
The Advantage of Outsourcing Fermentation-based Manufacturing Processes
Evonik Health Care
All supplier webinars